Cargando…
Use of Oral Anticoagulation and Diabetes Do Not Inhibit the Angiogenic Potential of Hypoxia Preconditioned Blood-Derived Secretomes
Patients suffering from tissue ischemia, who would greatly benefit from angiogenesis-promoting therapies such as hypoxia preconditioned blood-derived secretomes commonly receive oral anticoagulation (OA) and/or have diabetes mellitus (DM). In this study, we investigated the effect of OA administrati...
Autores principales: | Moog, Philipp, Jensch, Maryna, Hughes, Jessica, Salgin, Burak, Dornseifer, Ulf, Machens, Hans-Günther, Schilling, Arndt F., Hadjipanayi, Ektoras |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459715/ https://www.ncbi.nlm.nih.gov/pubmed/32796694 http://dx.doi.org/10.3390/biomedicines8080283 |
Ejemplares similares
-
Effect of Hypoxia Preconditioned Secretomes on Lymphangiogenic and Angiogenic Sprouting: An in Vitro Analysis
por: Moog, Philipp, et al.
Publicado: (2020) -
Comparison of the Effect of Different Conditioning Media on the Angiogenic Potential of Hypoxia Preconditioned Blood-Derived Secretomes: Towards Engineering Next-Generation Autologous Growth Factor Cocktails
por: Moog, Philipp, et al.
Publicado: (2023) -
Comparative Evaluation of the Angiogenic Potential of Hypoxia Preconditioned Blood-Derived Secretomes and Platelet-Rich Plasma: An In Vitro Analysis
por: Moog, Philipp, et al.
Publicado: (2020) -
Full-thickness dermal wound regeneration using hypoxia preconditioned blood-derived growth factors: A case series
por: Ektoras, Hadjipanayi, et al.
Publicado: (2023) -
Hypoxia Preconditioned Serum (HPS)-Hydrogel Can Accelerate Dermal Wound Healing in Mice—An In Vivo Pilot Study
por: Jiang, Jun, et al.
Publicado: (2022)